Radar › Companies › Life Sciences · Newport Beach
Radar · Life Sciences in Newport Beach

Best Life Sciences Companies in Newport Beach, United States

The 41 best Life Sciences companies in Newport Beach, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: AEON BioPharma.

41companies tracked
$223.2Mdisclosed funding
0unicorns
13have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × NEWPORT BEACH

Our analysis of 164 Life Sciences companies

$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

164companies analysed
83%cloud-native stacks
2025funding peak (by rounds)
7unicorns
2016median founding year

Ranked: Best Life Sciences companies in Newport Beach

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1AEON BioPharma
Provider of bio-therapeutics to treat nervous system-related conditions
$84M48 mo agoPublicMarc Forth
President and Chief Executive Officer
2018WordPressMySQLPHP+1678 patents
Patents concentrated in health & consumer products
—
2ViaLase
Developer of image-guided devices for glaucoma treatments
$45M29 mo agoSeries C—2018WordPressMySQLPHP+16134 patents
Ophthalmic laser surgical devices for precise eye-angle access and intraocular pressure control
—
3Bonti
Developing botulinum neurotoxins for the treatment of musculoskeletal pain
$36M103 mo agoAcquiredSusan Abushakra
Co-Founder & CMO
2015—84 patents
Formulating and producing botulinum neurotoxin therapeutics for medical and cosmetic applications.
—
4GABA Therapeutics
Developer of therapeutics for treating anxiety
$22M34 mo agoSeries ARichard Farrell
Co-Founder & CFO
2017———
5miraDry
Device for treating sweat and odor glands
$12M115 mo agoAcquired—2010WordPressSentryMySQL+3825 patents
Non‑invasive microwave tissue treatment devices for sweat‑gland ablation and hyperhidrosis therapy
—
6Advanced Bifurcation Systems
Developer of a self-aligning bifurcating stent for the treatment of cardiac health
$11M68 mo agoSeries A—2010WordPressMySQLPHP+9——
7jCyte
Developing innovative cell therapies for degenerative retinal disorders and optic nerve conditions
$4M89 mo agoSeries A—2012Apache HTTP ServerUserWayMicrosoft 365+411 patents
Low‑light visual mobility testing for ophthalmic diagnostic assessments
—
8PhageTech
Your source for SGP lottery results, data, and Singapore Togel
$3M111 mo agoSeries ARichard Henson
Co-Founder
2014—8 patents
Virus-based biosensors and bioelectronic devices for detecting biological analytes
—
9Medical Care Corporation
Cognitive assessment and neuroinformatics solutions for memory loss and brain health
$2M81 mo agoFunding Raised—1999—2,972 patents
Peritoneal dialysis monitoring, blood volume control, and interoperable medical device data transfer
—
10ICLED
Light guided suture delivery system for cosmetic surgery
$1M204 mo agoDeadpooledGregory Mueller
Co-Founder
2008———
11ElevateU
Developer of AI-powered platforms for research recruitment and opioid misuse reduction
$1M8 mo agoFunding RaisedRenee Garett
Founder & CEO
2022———
12Cartilage
Developer of biocompatible cartilage regeneration products
$508K66 mo agoFunding RaisedKiley Athanasiou
Co-Founder & CEO
2019———
13Aliviar Health
Symptom checker apps for common illnesses
$130K150 mo agoDeadpooledNiv Caviar
CEO
2012———

Top 12 Life Sciences companies in Newport Beach

#1
Funding Raised · Newport Beach, California · founded 2022
$1Mraised
▾

Developer of AI-powered platforms for research recruitment and opioid misuse reduction. One platform facilitates the connection between researchers and study participants, streamlining the recruitment process. The other platform is a peer support community and clinical counseling portal that uses AI to identify individuals at high risk for opioid addiction and overdose, aiding in preventative interventions. These technologies leverage clinical studies and data analysis to improve health outcomes.

Funding rounds
  • Dec 2025Grant (prize money)$270.6K
  • Aug 2023Grant (prize money)$270.6K
  • Jul 2022Grant (prize money)$224.6K
  • Jan 2022Grant (prize money)$239K
Founders & team
Renee GarettFounder & CEO
Investors
HHS
#2
Series C · Newport Beach, California · founded 2018 · 27 employees
$45.2Mraised
▾

Developer of image-guided devices for glaucoma treatments. The company focuses on the development of an image-guided femtosecond laser surgical system for the treatment of glaucoma.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 10.2% of this cohort's audience
Funding rounds
  • Mar 2024Series C$45.2M
  • Jan 2024Conventional Debt$3.5M
Investors
Venture Investors, Arboretum Ventures, Falcon-Vision
#3
Public · Newport Beach, California · founded 2018 · 9 employees
$84.5Mraised
▾

Provider of bio-therapeutics to treat nervous system-related conditions. The company's flagship product is ABP-450 which is 900 kDa pra botulinum toxin A and is used for patients suffering from disabling disorders.

Funding rounds
  • Aug 2022Post IPO$54.5M
  • Sep 2020Series B$30M
Founders & team
Marc ForthPresident and Chief Executive Officer
Investors
Daewoong Pharmaceutical, De novo ventures
Tech stack
AstraCloudflareCloudflare Browser InsightsCookieyesCore-JsDetectify
#4
Series A · Newport Beach, California · founded 2017 · 6 employees
$22Mraised
▾

GABA Therapeutics is developing a therapeutic agent for treating Central Nervous System disorders. The company has developed a proprietary drug called GRX-917 which is a benzodiazepine like Xanax with lower side effects used for the treatment of anxiety. The drug displays dual mechanisms is an improved version of Etifoxine.

Founders & team
Richard FarrellCo-Founder & CFOIan MasseyCEO
Investors
Forward Vision
#5
Acquired · Newport Beach, California · founded 2015 · 10 employees
$36Mraised
▾

Developing botulinum neurotoxins for the treatment of musculoskeletal pain. It is a clinical-stage company focused on developing neurotoxins for therapeutic & aesthetic applications using its proprietary platform. Its lead drug EB-001 is a novel serotype E botulinum neurotoxin (BoNT/E) being developed for the treatment of post-surgical and non-surgical musculoskeletal pain. EB-001 acts on muscle hyperactivity which is the main cause of musculoskeletal pain.

Funding rounds
  • Jan 2018Series C$15.5M
  • 2017Series B—
  • Apr 2017Series B$11.7M
  • Dec 2015Conventional Debt$2M
Founders & team
Susan AbushakraCo-Founder & CMO
Investors
City Hill, Viva Ventures Biotech Fund, SVB, RBV Capital, Colt Ventures, JMCR Partners
#6
Series A · Newport Beach, California · founded 2010 · 10 employees
$11Mraised
▾

Advanced Bifurcation Systems is a developer of a self-aligning bifurcating stent for the treatment of cardiac health. It has developed a self-aligning bifurcating stent that can be introduced into the vessels at the point of bifurcation and is used for coronary stenting.

Funding rounds
  • Dec 2020Series A$11M
Investors
Cedars Sinai
Tech stack
CloudflareHttp/3
#7
Acquired · Newport Beach, California · founded 2010 · 82 employees
$12.5Mraised
▾

Miradry Labs offers a miraDry, a noninvasive, FDA-cleared treatment to treat underarm sweat. It works by eliminating the sweat and odor glands. The healthcare provider applies local anesthesia at the region and marked. The device is used to remove the sweat and order glands.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers — 25.1% of this cohort's audience · 26 engagements/post (1.9× cohort median)
Activity: 1 partnerships (incl. myEvergreen MedSpa) announced in 12 mo
Funding rounds
  • Jan 2017Series D$2.5M
  • Feb 2014Series D$10M
Investors
Aisling Capital, Domain Associates, Morgenthaler, RusnanoMedInvest, Cross Creek
Tech stack
Amazon CloudfrontAmazon S3Amazon Web ServicesApache Http ServerCloudflareCloudflare Bot Management
#8
Series A · Newport Beach, California · founded 2012 · 10 employees
$3.9Mraised
▾

Developing innovative cell therapies for degenerative retinal disorders and optic nerve conditions. This biotech company is focused on preserving and restoring vision through its proprietary platform. They are developing first-in-class investigational treatments for retinitis pigmentosa (RP) and other inherited retinal and blinding diseases. Their approach involves cell therapy and regenerative medicine, with a focus on clinical development and regulatory submissions. They are passionate about developing transformative therapies to improve the lives of patients by developing best-in-class treatments for blinding diseases. They are working towards clinical trials, data analysis, and strategic partnerships to advance their pipeline of ophthalmic solutions.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 6.1% of this cohort's audience · 53 engagements/post (3.9× cohort median)
Funding rounds
  • Apr 2019Series A$3.9M
Tech stack
Apache Http ServerGodaddyGoogle AnalyticsGoogle Hosted LibrariesJqueryMicrosoft 365
#9
Series A · Newport Beach, California · founded 2014 · 10 employees
$2.9Mraised
▾

Your source for SGP lottery results, data, and Singapore Togel. This platform provides comprehensive information on Singapore's lottery, including SGP results, data, and Togel. It serves as a hub for enthusiasts seeking the latest updates on lottery outcomes, historical data, and insights into Togel Singapore. The website offers a user-friendly interface for accessing results, analyzing trends, and making informed decisions. It caters to individuals interested in lottery games, providing a reliable source for staying informed and engaged. The platform focuses on delivering accurate and timely information, ensuring users have access to the data they need. It is a valuable resource for anyone participating in or following the Singapore lottery scene. The site offers lottery results, historical data, and insights for informed participation.

Funding rounds
  • May 2017Series A$500K
  • Sep 2015Series A$2.4M
  • Nov 2014Seed—
Founders & team
Richard HensonCo-Founder
Investors
EvoNexus, Mark IV Capital, Black River, Cove Fund, Genechem, Octane
Tech stack
WixReactGoogle CloudPolyfillLodashPriority Hints
#10
Funding Raised · Newport Beach, California · founded 1999
$2Mraised
▾

Cognitive assessment and neuroinformatics solutions for memory loss and brain health. They provide solutions for clinical care, clinical research, biomarker development, and disease management. Their offerings include cognitive assessment tools, data mining capabilities, and intellectual property research. They focus on memory loss, brain health, MCI, dementia, and Alzheimer's, offering resources on causes, diagnosis, and treatment. They provide login access to existing accounts and new account creation for seamless access to patient data and assessment reports. They are a technology company offering software solutions in the healthcare space.

Funding rounds
  • Nov 2019Grant (prize money)$1.2M
  • Sep 2009Grant (prize money)$794.1K
Investors
NIH, HHS, BRV
Tech stack
JavaJava ServletJboss WebJboss Application ServerJquery
#11
Deadpooled · Newport Beach, California · founded 2008
$1.5Mraised
▾

Light guided suture delivery system for cosmetic surgery

Founders & team
Gregory MuellerCo-Founder
#12
Funding Raised · Newport Beach, California · founded 2019 · 3 employees
$508.1Kraised
▾

Developer of biocompatible cartilage regeneration products. These products aim to heal cartilage defects of various sizes in the knee and temporomandibular joint. The company utilizes technologies developed at a leading university to create implants and processes for cartilage repair, addressing the significant unmet need for effective cartilage healing solutions. Current offerings are limited to research use only pending FDA approval.

Funding rounds
  • Feb 2021Grant (prize money)$256K
  • Sep 2020Grant (prize money)$252.1K
Founders & team
Kiley AthanasiouCo-Founder & CEORyan DonahueCo-FounderWendy BrownCo-Founder
Investors
HHS

Funding & investor landscape

$223.2Mtotal disclosed funding
15companies funded
25disclosed rounds
0rounds last 90 days
Most active investors
HHS3 rounds
AAF Management1 rounds
Additio Ventures1 rounds
Aisling Capital1 rounds
Arab Angel1 rounds
Arboretum Ventures1 rounds
BRV1 rounds
Black River1 rounds
Cedars Sinai1 rounds
City Hill1 rounds

Notable founders

Renee Garett
Founder & CEO · ElevateU
Marc Forth
President and Chief Executive Officer · AEON BioPharma
Richard Farrell
Co-Founder & CFO · GABA Therapeutics
Ian Massey
CEO · GABA Therapeutics
Susan Abushakra
Co-Founder & CMO · Bonti
Richard Henson
Co-Founder · PhageTech
Gregory Mueller
Co-Founder · ICLED
Kiley Athanasiou
Co-Founder & CEO · Cartilage
Ryan Donahue
Co-Founder · Cartilage
Milton III
Founder · Ault Life Sciences
Niv Caviar
CEO · Aliviar Health
Prism market signals · United States · country-scoped Prism corpus, 1,465,538 docs

Market landscape — 10 sub-themes by coverage

Share of Life Sciences coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH SIGNALS · United States

How research on Biotechnology is moving in the United States

A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.

research sentiment over time
200820162026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and steady — the enthusiastic (strongly-positive) share moved 44% → 42% across 2008–2026.
top research entities
  • Harvard University209
  • Cornell University177
  • University of Tennessee at Chattanooga140
  • Howard Hughes Medical Institute126
  • Johns Hopkins University121
leading researchers
Stylianos Chatzimanolis · TARIK DEDOVIC · KATH-RYN ANN F. HANKINS · Christoforos Pavlou · Giannis Bolanakis · Ashley R Tetens · Tyler Findlay · Jordyn Craig-Schwartz
▲ Breakthroughs2,038 · 33%
▼ 41%→30% share
▼0.7× share momentum0 median citations71% since 2021mostly empirical
Breakthroughs are cooling (41%→30% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene33→164
  • Transcription (linguistics)11→79
  • Antibody11→62
  • Genome6→56
  • Mutation7→56
Newly emergingIdentification (biology) 0→18 · Function (biology) 0→18 · Reporter gene 0→16
Landmark U1 snRNP regulates cancer cell migration and invasion in vitro · 7,224 cites
◆ Advancements2,118 · 34%
▲ 29%→35% share
▲1.2× share momentum0 median citations80% since 2021mostly empirical
Advancements are rising (29%→35% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene8→110
  • Cell culture3→62
  • Gene expression3→62
  • Fermentation2→54
  • Downregulation and upregulation1→50
Newly emergingIdentification (biology) 0→27 · Probiotic 0→24 · Cultivar 0→23
Landmark Using Deep Learning for Image-Based Plant Disease Detection · 4,262 cites
▼ Concerns1,006 · 16%
▼ 17%→15% share
▼0.9× share momentum0 median citations73% since 2021mostly empirical
Concerns are cooling (17%→15% of field), led by Agriculture.
rising sub-themes (early→recent)
  • Agriculture19→58
  • Antibiotic resistance15→45
  • Public health4→31
  • Gene6→30
  • Production (economics)5→29
Newly emergingQuality (philosophy) 0→27 · Animal health 0→14 · Integrated pest management 0→13
Landmark The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate · 8,812 cites
RESEARCH HOTSPOTS · United States

Where biotechnology is researched across United States

Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.

Boston351 · +0.52
Hot · Cancer researchAdvancing · Nucleic acidOpportunity · Strain (injury)Concern · Antibiotics
New York319 · +0.47
Hot · GermplasmAdvancing · Genomic selectionOpportunity · CellConcern · Agriculture
SF Bay Area235 · +0.57
Hot · Near-infrared spectroscopyAdvancing · Fluorescence-lifetime imaging microscopyOpportunity · ReceptorConcern · Biochemical engineering
Philadelphia115 · +0.60
Hot · Chimeric antigen receptorAdvancing · Genetically modified mouseOpportunity · Transgene
San Diego101 · +0.59
Hot · Recombinant DNAAdvancing · Gene knockdownOpportunity · Cell cultureConcern · Cancer cell
Seattle95 · +0.46
Hot · Polymerase chain reactionAdvancing · Monoclonal antibodyOpportunity · Downregulation and upregulation
Chicago95 · +0.57
Hot · AntigenAdvancing · Untranslated regionOpportunity · Transcription factor
Los Angeles93 · +0.61
Hot · NucleaseAdvancing · GenomicsOpportunity · Cell
Pittsburgh65 · +0.54
Hot · MutationAdvancing · Nucleic acidOpportunity · Gene
Ann Arbor65 · +0.58
Hot · Cell cultureAdvancing · Identification (biology)Opportunity · Mutant
PATENT SIGNAL · United States

Who's filing biotechnology patents in the United States

United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.

457,918 filings8,000 assigneespeak 51616/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
  • Genentech18078
  • UNIV California17948
  • Regeneron Pharma16082
  • Amgen10495
  • Monsanto Technology9742
  • UNIV Pennsylvania8521
  • Harvard College7460
  • UNIV Texas7378

Common questions

How many Life Sciences companies are there in Newport Beach, United States?
Radar tracks 41 indexable Life Sciences companies headquartered in Newport Beach, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Newport Beach, United States?
The Life Sciences companies in Newport Beach, United States on this list have raised a combined $223.2M in disclosed equity funding across 15 funded companies.
Which is the highest-funded Life Sciences company in Newport Beach, United States?
AEON BioPharma is the highest-funded Life Sciences company in Newport Beach, United States, with $84.5M in disclosed equity funding.
How many Life Sciences companies in Newport Beach, United States are funded?
15 of the 41 Life Sciences companies in Newport Beach, United States on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Newport Beach, United States?
None of the Life Sciences companies in Newport Beach, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Newport Beach, United States Life Sciences companies?
The most active investors in Newport Beach, United States Life Sciences companies on this list include HHS, AAF Management, Additio Ventures, Aisling Capital, Arab Angel.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon